Aug 2026· Pharmacological Research· Vol 231, pp.
108394
· 0 citations· 252 references
Medicine
TL;DR
This review synthesizes current understanding of subunit-specific AMPAR-mediated pathological mechanisms in AD and discusses emerging pharmacological strategies targeting AMPARs as potential therapeutic approaches to delay or attenuate disease progression.
Abstract
AMPA receptors (AMPARs) mediate fast excitatory neurotransmission and play central roles in synaptic plasticity, learning, and memory. They are heterotetrameric complexes organized as two dimers, with subunits from GluA1 to GluA4. Dysregulation of AMPAR trafficking, localization, and function has been increasingly implicated in amyloid beta (Aβ)- and tau-associated synaptic deficits, which are the pathological hallmarks for Alzheimer's disease (AD). Accumulating evidence suggests that AMPARs play distinct, subunit-specific roles in synaptic plasticity and learning and memory in physiological and pathological contexts. This review synthesizes current understanding of subunit-specific AMPAR-mediated pathological mechanisms in AD and discusses emerging pharmacological strategies targeting AMPARs as potential therapeutic approaches to delay or attenuate disease progression.
Alzheimer's disease (AD) is the leading cause of dementia and still lacks an effective treatment that can slow or stop disease progression. In addition to amyloid-β and tau pathology, AD involves major disturbances in calcium balance, neurotransmission, and synaptic plasticity. Conventional orthosteric drugs provide li...
A. Fereidouni, Setayesh Nematollahi, K. T. Mathew et al.· International Journal of Bio...· 0 citations
AMPA receptors (AMPARs) facilitate excitatory neurotransmission and are implicated in neurological and neuropsychiatric disorders. Binding of the neurotransmitter glutamate triggers AMPAR activation, which is modulated by potentiating and inhibitory auxiliary subunits. While modulation by potentiating auxiliary subunit...
Thomas P. Newton, M. Yelshanskaya, Muhammed Aktolun et al.· Nature Communications· 0 citations
Synaptic dysfunction and intracellular accumulation of pathological tau are convergent hallmarks of Alzheimer’s disease (AD) and related tauopathies, yet the molecular mechanisms coupling these events to widespread neurodegeneration remain incompletely understood. The Src family kinase Fyn has emerged as a critical sig...
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPA receptors) are ionotropic glutamate receptors that mediate fast excitatory neurotransmission in the central nervous system. By translating chemical signals into rapid electrical depolarization, AMPA receptors, together with NMDA and kainate receptors,...
Alessio Spinola, Maria Italia, F. Gardoni· Biomedicine & pharmacotherap...· 0 citations
Glutamate, the principal excitatory neurotransmitter in the brain, plays a central role in neurotransmission, synaptic plasticity, and cognitive function. Dysregulation of glutamatergic signaling is implicated in depression, schizophrenia (SCZ), and addiction. N-methyl-Daspartate receptor/α-amino-3-hydroxy-5-methyl-4-...
Wen-Jing Shi, Jie Bai· Actas espanolas de psiquiatr...· 0 citations
Silent synapses represent a unique class of synaptic connections that are non-functional at rest but possess the potential to become functional, serving as a critical reservoir for neural plasticity. Their activation mechanisms not only challenge traditional models of synaptic maturation but also provide novel insights...
Yong-Li Li, Yong Liao, Shou-Yao Zhang et al.· Frontiers in Synaptic Neuros...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
